TAR-200 monotherapy shows greater than 80 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer

Posted on May 6, 2024 by Danzig

Here is the original post:
TAR-200 monotherapy shows greater than 80 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer

Related Posts

Novan to Present at the Virtual Investor KOL Roundtable [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360° [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™ [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Telo Genomics Announces Warrant Exercise Agreement [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
The Quest for Blockbuster Drugs Continues [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Artelo Biosciences Files Patent on Use of Fatty Acid Binding Protein 5 Inhibitors for Treating Psychological Disorders [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Studies in Endometriosis and Uterine Fibroids [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
SCYNEXIS to Present Data Supporting the Efficacy of Ibrexafungerp Against Invasive Fungal Infections at IDWeek 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Radius Health, Inc.: Progress Since May 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy... [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Immutep Granted European Patent for IMP761 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Teneobio Announces a Research Collaboration and License Agreement With ArsenalBio [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
AzurRx BioPharma Announces Formation of Scientific Advisory Board [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Turning Point Therapeutics Announces Abstract For TRIDENT-1 Clinical Study of Repotrectinib Accepted For Presentation at World Conference on Lung... [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Trevi Therapeutics Provides Clinical Trial Updates for Haduvio™ [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Neumentum and Nuance Biotech Enter into Licensing Agreement for NTM-001 (ketorolac for IV infusion) in China [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business... [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
Vir Biotechnology Presents New Data on VIR-2482, the Company’s Investigational Monoclonal Antibody for the Prevention of Influenza A, at IDWeek 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
XORTX Participation in Virtual Conferences [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Tauriga Sciences, Inc. Updates Shareholders on New York State's Determination to Allow the Sale of CBD Edibles in the Forms of Food & Drink [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Zenith Confirms Interim Filings on SEDAR [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Trading by management and close relations of management [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
AXIM® Biotechnologies Issues Update Letter to Shareholders [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
One World’s Dr. Kenneth Perego Joins Montel Williams for Blunt Discussion [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Scout Bio Advances Novel Gene Therapy for the Treatment of Feline Diabetes [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Pandion Therapeutics Highlights Potential of Modular Biologics Pipeline for the Treatment of Autoimmune Diseases at FOCIS 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Rhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North America [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Kane Biotech builds upon successful results with launch of a US Consumer Test [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
VYNE Therapeutics to Report Third Quarter 2020 Financial Results on November 5th [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
BetterLife Provides Important Update on its Australian Clinical Study Design [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Iovance Biotherapeutics to Present at Upcoming Conferences in November [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Otonomy to Report Third Quarter 2020 Financial Results and Provide Corporate Update [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Kraig Biocraft Laboratories Delivers Recombinant Spider Silk Silkworm Eggs to Production Facility in Vietnam [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Verona Pharma plc : Update on AIM Delisting [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes & Endocrinology [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
CymaBay Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial for Hypertrophic Scars [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Nobilis Therapeutics to Present at CapCon 2020 Venture Conference [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Generex Subsidiary NuGenerex Immuno-Oncology Announces Appointment of Dr. Tamera Coyne-Beasley to the Scientific Advisory Board for its COVID-19... [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
MHRA Grants HAE Patients Early Access to BioCryst’s Berotralstat in United Kingdom [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Aligos Therapeutics Doses First Subject in Phase 1 Proof-of-Concept Study of Small Molecule Drug Candidate ALG-000184 for Chronic Hepatitis B [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
BioVie Interview to Air on Bloomberg International on the RedChip Money Report [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Chiasma Reinforces Commitment to People with Acromegaly and Advocacy Organizations on Acromegaly Awareness Day [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Chi-Med to Attend Upcoming Industry and Investor Virtual Conferences [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Innovation Pharmaceuticals and George Mason University Announce Public Release of Laboratory Testing Results Demonstrating Brilacidin’s COVID-19... [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami) [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials of Tavapadon for the Treatment of Parkinson’s Disease [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
Reata Pharmaceuticals, Inc. to Report Third Quarter 2020 Financial Results and Provide an Update on Development Programs on November 9, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Syneos Health to Present at Upcoming Investor Conferences [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Terranueva Announces Changes to Its Management Team [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Satsuma Pharmaceuticals to to participate in the following November Virtual Investor Conferences [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Latest Wound Care Research from Organogenesis Highlighted at SAWC Fall 2020 Virtual Meeting [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Trillium Therapeutics Announces Formation of Scientific Advisory Board [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Neuronetics Reports Third Quarter 2020 Financial and Operating Results [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial Results [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
MediWound to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 10, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Cara Therapeutics to Announce Third Quarter 2020 Financial Results on November 9, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Nabriva Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Opiant Pharmaceuticals to Participate at the Jefferies 2020 Virtual London Healthcare Conference [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Intercept to Announce Third Quarter 2020 Financial Results on November 9, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
Inventiva announces the publication of a scientific paper on the role of PPARs in the treatment of NASH in the medical journal Nature Review... [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]

Comments are closed.